SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001507567-23-000003
Filing Date
2023-01-05
Accepted
2023-01-05 16:21:33
Documents
1
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167295366118350.html 4  
1 FORM 4 wf-form4_167295366118350.xml 4 6672
  Complete submission text file 0001507567-23-000003.txt   8265
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE CA 94085
Business Address
Booth Robert F. (Reporting) CIK: 0001507567 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 23511612

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations